Suchergebnisse - "Wise, David R"

PubPharm (40)

1

TARGET : A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing

enthalten in: JCO precision oncology | 2024

von Loeb, S. | Keith, S. | Cheng, H. | +19

2

High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapy

enthalten in: Radiation oncology (London, England) | 2024

von Lischalk, J. | Sanchez, A. | Santos, V. | +12

3

Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate Cancer

enthalten in: Clinical genitourinary cancer | 2024

von Economides, M. | Nakazawa, M. | Lee, J. | +7

4

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

enthalten in: Prostate cancer and prostatic diseases | 2024

von Wise, D. | Pachynski, R. | Denmeade, S. | +29

5

Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer : The PROCLAIM Trial

enthalten in: European urology oncology | 2023

von Shore, N. | Gazi, M. | Pieczonka, C. | +25

6

A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

enthalten in: Molecular cancer therapeutics | 2023

von Habault, J. | Schneider, J. | Ha, S. | +15

7

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile

enthalten in: The Prostate | 2023

von Adorno Febles, V. | Hao, Y. | Ahsan, A. | +19

8

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors : The JAVELIN PARP Medley Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2023

von Yap, T. | Bardia, A. | Dvorkin, M. | +17

CommentOn: JAMA Oncol. 2023 Jan 1;9(1):25-27. - PMID 36394835

9

Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET) : A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing

enthalten in: Contemporary clinical trials | 2022

von Loeb, S. | Cheng, H. | Leader, A. | +23

10

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer

enthalten in: JNCI cancer spectrum | 2022

von Shah, N. | Patel, V. | Zhong, X. | +19